Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS)

Historical Holders from Q1 2022 to Q3 2025

Type / Class
Equity / Ordinary Shares, no par value
Symbol
DRTS on Nasdaq
Shares outstanding
86,723,804
Price per share
$4.51
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
1,832,497
Total reported value
$8,263,970
% of total 13F portfolios
0%
Share change
+245,804
Value change
+$1,145,345
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
31
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ORAMED PHARMACEUTICALS INC. 20% $35,980,809 14,110,121 Oramed Pharmaceuticals Inc. 24 Apr 2025
Sofer Uzi 16% $37,818,516 13,702,361 Uzi Sofer 31 Dec 2022
As of 30 Sep 2025, Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) has 31 institutional shareholders filing 13F forms. They hold 1,832,497 shares. of 86,723,804 outstanding shares (2.1%) .

Institutional Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 1,832,497 $8,263,970 +$1,145,345 451% 31
2025 Q2 1,586,693 $4,950,874 +$1,313,729 312% 24
2025 Q1 1,172,124 $2,940,869 +$461,245 251% 23
2024 Q4 976,001 $3,025,475 +$134,426 310% 21
2024 Q3 948,076 $2,228,639 -$143,072 238% 23
2024 Q2 1,296,861 $3,253,557 -$610,750 253% 24
2024 Q1 355,626 $1,015,675 -$71,635 295% 5
2023 Q4 1,840,525 $5,505,585 +$1,681,256 301% 26
2023 Q3 975,005 $3,652,424 +$100,189 379% 23
2023 Q2 932,296 $4,074,257 +$2,059,369 437% 18
2023 Q1 652,086 $1,871,091 +$336,132 287% 16
2022 Q4 533,823 $1,697,581 -$884,134 318% 13
2022 Q3 686,488 $4,006,000 -$9,740 584.01% 15
2022 Q2 653,675 $5,920,000 +$1,784,954 900.91% 13
2022 Q1 447,472 $5,281,000 +$5,281,007 1,180.75% 11